VersaBank ( VBNK ) declares CAD 0.025/share quarterly dividend , in line with previous. Payable July 31; for shareholders of record July 10; ex-div July 10. See VBNK Dividend Scorecard, Yield Chart, & Dividend Growth. More on VersaBank VersaBank: A Quiet Winner VersaBank (VBNK:CA) Shareholder/Analyst Call Transcript VersaBank 2026 Q1 - Results - Earnings Call Presentation VersaBank sells lone U.S....
VersaBank ( VBNK ) declares CAD 0.025/share quarterly dividend , in line with previous. Payable July 31; for shareholders of record July 10; ex-div July 10. See VBNK Dividend Scorecard, Yield Chart, & Dividend Growth. More on VersaBank VersaBank: A Quiet Winner VersaBank (VBNK:CA) Shareholder/Analyst Call Transcript VersaBank 2026 Q1 - Results - Earnings Call Presentation VersaBank sells lone U.S. branch to Stearns Bank Historical earnings data for VersaBank
Celcuity ( NASDAQ: CELC ) on Wednesday said that it plans to offer $400 million of convertible senior notes due 2032 in an underwritten public offering. The clinical-stage biotechnology company said it expects to grant underwriters a 30-day option to purchase up to an additional $60 million of notes to cover over-allotments. The unsecured senior notes will mature on August 1, 2032, unless earlier ...
Celcuity ( NASDAQ: CELC ) on Wednesday said that it plans to offer $400 million of convertible senior notes due 2032 in an underwritten public offering. The clinical-stage biotechnology company said it expects to grant underwriters a 30-day option to purchase up to an additional $60 million of notes to cover over-allotments. The unsecured senior notes will mature on August 1, 2032, unless earlier converted, redeemed, or repurchased. The interest rate, conversion rate, offering price, and other terms will be determined at pricing. Celcuity said it intends to use the net proceeds to repay all outstanding obligations under its loan agreement with Oxford Finance and use the remaining funds for working capital and general corporate purposes, including clinical trials, commercialization activities, research and development, capital expenditures, and business development. The company said completion of the offering remains subject to market and other conditions, and there is no assurance regarding its timing, size, or final terms. Source: Press Release More on Celcuity Celcuity Inc. (CELC) Discusses VIKTORIA-1 Trial Results for PIK3CA Mutant Advanced Breast Cancer and Gedatolisib Efficacy Transcript Celcuity: Approaching An Inflection Point With Gedatolisib Celcuity Inc. (CELC) Q1 2026 Earnings Call Transcript These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations Celcuity falls after detailed late-stage trial data for breast cancer drug
Shares of Indian software services companies are experiencing their sharpest swings since the pandemic, as the growing prowess of artificial intelligence fuels investor anxiety about the industry. NSE Nifty IT Index opened about 1.8% lower on Wednesday and extended the fall to as much as 5.8% before closing. Intraday swings of more than 4% have now occurred six times so far this year, the highest ...
Shares of Indian software services companies are experiencing their sharpest swings since the pandemic, as the growing prowess of artificial intelligence fuels investor anxiety about the industry. NSE Nifty IT Index opened about 1.8% lower on Wednesday and extended the fall to as much as 5.8% before closing. Intraday swings of more than 4% have now occurred six times so far this year, the highest frequency in the decade outside the pandemic period. The move also marked a sharp reversal of the gauge’s 5% advance a day before. Software services firms have emerged as the biggest laggards in India’s $4.9 trillion stock market this year, as investors reassess their growth outlook amid fears of AI-related disruption. Tata Consultancy Services tumbled more than 8% in its biggest single-day drop since early 2020. The slide followed a 6.5% rally in the previous session, highlight how hopes of a recovery have proved fleeting. The stock has slumped 29% so far this year, outpacing the 22% drop in the sector gauge. READ: India Tech Giants Struggle to Shake Off $115 Billion Rout “Software stocks have turned extremely sensitive to newsflow even though broader pessimism continues to hold for the sector,” said Sonam Srivastava , founder of Wright Research Portfolio Management Services. She said the latest decline in software stocks coincides with large share-sale and fundraising announcements from global firms including Anthropic PBC . READ: AI Scare’s $56 Billion Hit Tests Resilience of India’s IT Stocks Adding to signs of investor anxiety, realized volatility in technology stocks has risen to its highest level since the pandemic-era market turmoil. The NSE Nifty IT Index’s realized volatility is now above 50%, the highest reading since 2020 outside the Covid-induced spike that briefly sent volatility above 110%.
The iShares Core High Dividend ETF (NYSEMKT:HDV) may appeal to income-focused investors who prioritize defensive stability, while the Fidelity High Dividend ETF (NYSEMKT:FDVV) looks better for those seeking higher growth potential. Both funds target dividend-paying U.S. equities, yet they take very different paths to achieve that goal. While HDV prioritizes established, lower-volatility companies,...
The iShares Core High Dividend ETF (NYSEMKT:HDV) may appeal to income-focused investors who prioritize defensive stability, while the Fidelity High Dividend ETF (NYSEMKT:FDVV) looks better for those seeking higher growth potential. Both funds target dividend-paying U.S. equities, yet they take very different paths to achieve that goal. While HDV prioritizes established, lower-volatility companies, FDVV integrates growth-oriented sectors, resulting in distinct risk profiles for income-focused investors who must choose between sector stability and growth exposure. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
designer491/iStock via Getty Images Market review and outlook The world financial markets, after performing well in the first two months of the year on continued optimism about trends in economic growth and interest rates, turned lower following the start of the conflict in the Middle East in early March. The ensuing spike in oil prices, together with concerns about possible shortages of other com...
designer491/iStock via Getty Images Market review and outlook The world financial markets, after performing well in the first two months of the year on continued optimism about trends in economic growth and interest rates, turned lower following the start of the conflict in the Middle East in early March. The ensuing spike in oil prices, together with concerns about possible shortages of other commodities caused by disrupted supply chains, dampened the growth outlook and led to a sharp rise in inflation expectations. The deteriorating inflation picture, in turn, dashed optimism that central banks could continue cutting rates. In combination, these developments led to a surge in global government bond yields that erased the positive total returns achieved in the first two months of the year. The conflict also fueled a sizable downturn in major global equity indexes in March, sending stocks into the red. With this said, the majority of the negative return for equities stemmed from weakness in the growth style in general and mega-cap U.S. technology stocks in particular. Conversely, the value style, dividend payers, and more defensive companies generally produced positive returns, benefiting diversified investors. We're encouraged by the broadening of leadership away from the "Magnificent Seven" group of U.S. tech companies, as it provided a tailwind for our diversified positioning. Contributors and detractors The fund's modest underperformance was almost entirely due to its overweight position in equities and its corresponding underweight in bonds. On the positive side, we benefited from having an underweight in U.S. large caps in favor of an overweight in U.S. mid caps. Underlying manager performance contributed, highlighted by relative strength in international equities. Portfolio changes The broader investment picture was very much in flux at the end of the quarter. While near-term trends in economic growth and corporate earnings remained positive, the conflict in ...
Avalyn Pharma press release ( AVLN ): Q1 net loss was $26.9 million for the first quarter of 2026, as compared to $17.5 million for the first quarter of 2025. Cash, cash equivalents, and marketable securities were $123.1 million as of March 31, 2026. More on Avalyn Pharma Inc. Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline Lung disease drug developer Avalyn surges on public debut...
Avalyn Pharma press release ( AVLN ): Q1 net loss was $26.9 million for the first quarter of 2026, as compared to $17.5 million for the first quarter of 2025. Cash, cash equivalents, and marketable securities were $123.1 million as of March 31, 2026. More on Avalyn Pharma Inc. Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline Lung disease drug developer Avalyn surges on public debut Avalyn Pharma prices $300M IPO at $18 per share Historical earnings data for Avalyn Pharma Inc. Financial information for Avalyn Pharma Inc.
The United States market has recently seen a 1.2% increase over the past week and an impressive 27% rise over the last year, with earnings expected to grow by 17% annually. In this thriving environment, identifying high-growth tech stocks involves focusing on companies with strong innovation potential and scalability that align well with these positive market trends.
The United States market has recently seen a 1.2% increase over the past week and an impressive 27% rise over the last year, with earnings expected to grow by 17% annually. In this thriving environment, identifying high-growth tech stocks involves focusing on companies with strong innovation potential and scalability that align well with these positive market trends.
The United States market has shown robust performance recently, climbing 1.2% in the last week and rising an impressive 27% over the past year, with earnings expected to grow by 17% annually. In this environment, identifying stocks that may be priced below their estimated worth can offer potential opportunities for investors seeking value amidst overall market growth.
The United States market has shown robust performance recently, climbing 1.2% in the last week and rising an impressive 27% over the past year, with earnings expected to grow by 17% annually. In this environment, identifying stocks that may be priced below their estimated worth can offer potential opportunities for investors seeking value amidst overall market growth.
AGT Food and Ingredients (TSX: AGTF) on Wednesday said that the Toronto Stock Exchange had accepted its notice to launch a normal course issuer bid to repurchase and cancel up to 3.38 million common shares, representing about 5% of its outstanding shares. The company said it had 67.63 million common shares outstanding as of May 31, 2026. Purchases under the buyback program may begin on June 5, 202...
AGT Food and Ingredients (TSX: AGTF) on Wednesday said that the Toronto Stock Exchange had accepted its notice to launch a normal course issuer bid to repurchase and cancel up to 3.38 million common shares, representing about 5% of its outstanding shares. The company said it had 67.63 million common shares outstanding as of May 31, 2026. Purchases under the buyback program may begin on June 5, 2026, and continue until June 4, 2027, or earlier if the maximum number of shares is acquired. AGT may buy up to 19,998 shares per trading day, subject to Toronto Stock Exchange rules. AGT said it believes its shares may at times trade below their value based on the company's financial performance and prospects. The company also said it had entered into an automatic share purchase plan with an independent broker, allowing purchases under the program during trading blackout periods, subject to regulatory requirements and the plan's terms. Source: Press Release More on AGT Food and Ingredients Inc. AGT Food and Ingredients Inc. (AGTF:CA) Q1 2026 Earnings Call Transcript AGT Food and Ingredients Inc. (AGTF:CA) Q4 2025 Earnings Call Transcript AGT Food and Ingredients Inc. 2025 Q4 - Results - Earnings Call Presentation Historical earnings data for AGT Food and Ingredients Inc. Financial information for AGT Food and Ingredients Inc.
Wellington Management has agreed to acquire Hartford Funds from The Hartford ( HIG ) in a move that strengthens its footprint in the actively managed mutual fund and ETF space. Upon closing, Hartford Funds will be integrated into Wellington’s U.S . Wealth business, and going forward the business will operate under the Wellington brand. "This transaction allows us to realize immediate and continued...
Wellington Management has agreed to acquire Hartford Funds from The Hartford ( HIG ) in a move that strengthens its footprint in the actively managed mutual fund and ETF space. Upon closing, Hartford Funds will be integrated into Wellington’s U.S . Wealth business, and going forward the business will operate under the Wellington brand. "This transaction allows us to realize immediate and continued value for The Hartford’s shareholders and positions Hartford Funds’ exceptional people for ongoing success. This combination creates the ideal long-term home for Hartford Funds," said C hristopher Swift, Chairman and CEO of The Hartford’s. The financial terms of the acquisition were not disclosed. More on The Hartford The Hartford: Strong Cash Flows, But Not A Clean Growth Story The Hartford Insurance Group, Inc. 2026 Q1 - Results - Earnings Call Presentation The Hartford Insurance Group, Inc. (HIG) Q1 2026 Earnings Call Transcript Hartford outlines Business Insurance expense ratio below 30% by end of 2027 while planning 30 agency states by early 2027 The Hartford Q1 2026 Earnings Preview
VersaBank press release ( VBNK ): Q2 Non-GAAP EPS of C$0.39. Revenue of C$38.29M (+27.0% Y/Y). More on VersaBank VersaBank: A Quiet Winner VersaBank (VBNK:CA) Shareholder/Analyst Call Transcript VersaBank 2026 Q1 - Results - Earnings Call Presentation VersaBank sells lone U.S. branch to Stearns Bank Historical earnings data for VersaBank
VersaBank press release ( VBNK ): Q2 Non-GAAP EPS of C$0.39. Revenue of C$38.29M (+27.0% Y/Y). More on VersaBank VersaBank: A Quiet Winner VersaBank (VBNK:CA) Shareholder/Analyst Call Transcript VersaBank 2026 Q1 - Results - Earnings Call Presentation VersaBank sells lone U.S. branch to Stearns Bank Historical earnings data for VersaBank